Cardiff Oncology Inc (CRDF)

Cardiff Oncology to Present at Upcoming Investor Conferences in May - GlobeNewswire

GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences in May

GlobeNewswire Inc.

Cardiff Oncology, Inc. Forecasted to Post FY2024 Earnings of ($0.98) Per Share (NASDAQ:CRDF) - Defense World

Defense World

FY2024 Earnings Forecast for Cardiff Oncology, Inc. (NASDAQ:CRDF) Issued By HC Wainwright - MarketBeat

MarketBeat

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 - PrimePublishers.com

PrimePublishers.com

Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Singapore News

Yahoo Singapore News

Cardiff Oncology's (CRDF) Buy Rating Reiterated at HC Wainwright - Defense World

Defense World

The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 - InvestorPlace

InvestorPlace

Cardiff Oncology (NASDAQ:CRDF) Rating Reiterated by HC Wainwright - MarketBeat

MarketBeat

Take the Zacks Approach to Beat the Markets: Navios Maritime, Coinbase Global, Virtu Financial in Focus

Zacks Investment Research

Cardiff Oncology (NASDAQ:CRDF) Rating Reiterated by HC Wainwright - MarketBeat

MarketBeat

Head to Head Comparison: Cardiff Oncology (NASDAQ:CRDF) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World

Defense World

Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Yahoo Finance

Earnings call: Cardiff Oncology reports on CRDF-004 trial progress - Investing.com India

Investing.com India

Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Cardiff Oncology earnings beat by $0.03, revenue topped estimates - Investing.com South Africa

Investing.com South Africa

Cardiff Oncology: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - GlobeNewswire

GlobeNewswire

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - GlobeNewswire

GlobeNewswire

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

GlobeNewswire Inc.

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update - GlobeNewswire

GlobeNewswire

Net Present Value Model: Cardiff Oncology Inc's Onvansertib Fumarate - GlobalData

GlobalData

Understanding the Risks of Investing in Cardiff Oncology Inc (CRDF) – Knox Daily - Knox Daily

Knox Daily

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

GlobeNewswire Inc.

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS ... - GlobeNewswire

GlobeNewswire

Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks Investment Research

Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Yahoo Finance

Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? - PR Newswire

PR Newswire

Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why

Zacks Investment Research

Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5 - InvestorPlace

InvestorPlace

Here's Why Momentum in Cardiff Oncology (CRDF) Should Keep going

Zacks Investment Research

Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?

Zacks Investment Research

Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach? - Marketscreener.com

Marketscreener.com

Should You Buy Cardiff Oncology Inc (CRDF) Stock After it Is Up 46.27% in a Week? - InvestorsObserver

InvestorsObserver

Will Cardiff Oncology Inc (CRDF) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

InvestorsObserver

Cardiff Oncology: Why The Bulls Are Winning Right Now (Rating Upgrade) (NASDAQ:CRDF) - Seeking Alpha

Seeking Alpha

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024

GlobeNewswire Inc.

What Makes Cardiff Oncology (CRDF) a Strong Momentum Stock: Buy Now?

Zacks Investment Research

Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $14.00 - MarketBeat

MarketBeat

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher

Benzinga

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Finding Long Term Penny Stocks Investments? 3 Tips

PennyStocks

Penny Stocks & Cryptocurrency, How Are They Related?

PennyStocks

We're Not Very Worried About Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Rate - Simply Wall St

Simply Wall St

Crude Oil Rises Over 2%; Fisker Shares Plummet

Benzinga

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February

Benzinga

Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga

Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results - Yahoo Finance

Yahoo Finance